Volume | 30,615,492 |
|
|||||
News | (1) | ||||||
Day High | 0.0011 | Low High |
|||||
Day Low | 0.0008 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
RespireRx Pharmaceuticals Inc (PK) | RSPI | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0011 | 0.0008 | 0.0011 | 0.00084 | 0.001 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
101 | 30,615,492 | $ 0.000929 | $ 28,430 | - | 0.0006 - 0.0191 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:56:45 | 20,000 | $ 0.00084 | USD |
RespireRx Pharmaceuticals Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 220.73M | 77.95M | 0 | -3.97M | -0.01 | 0.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
RespireRx Pharmaceuticals (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RSPI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0013 | 0.0015 | 0.0008 | 0.0010831 | 28,984,691 | -0.00046 | -35.38% |
1 Month | 0.0008 | 0.0043 | 0.0008 | 0.0015862 | 28,900,296 | 0.00004 | 5.0% |
3 Months | 0.00125 | 0.0043 | 0.0006 | 0.0014332 | 12,451,346 | -0.00041 | -32.8% |
6 Months | 0.0029 | 0.0043 | 0.0006 | 0.0014455 | 7,093,719 | -0.00206 | -71.03% |
1 Year | 0.004 | 0.0191 | 0.0006 | 0.0017849 | 4,045,586 | -0.00316 | -79.0% |
3 Years | 0.0028 | 0.095 | 0.0006 | 0.0061438 | 2,087,372 | -0.00196 | -70.0% |
5 Years | 0.705 | 0.85 | 0.0006 | 0.0069514 | 3,899,868 | -0.70416 | -99.88% |
RespireRx Pharmaceuticals (PK) Description
RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions. |